MAPK7 and sarcoma: To analyze whether targeting ERK5 with JWG-071 affects tumor growth in vivo, cells of two sarcoma cell lines (GCT and SJCRH30) were injected into the dorsal flanks of nude mice, and the action of the drug on the growth of the xenografts was monitored over time.